DarioHealth Corp.
Company & revenue
About DarioHealth Corp.
Financial breakdown: year ended 2025-12-31
Who they are
DarioHealth Corp. is a digital therapeutics enterprise operating across the United States, Canada, the European Union, Australia, and New Zealand. The company delivers a suite of digital health solutions, including its 'Dario' metabolic programs designed to address conditions like diabetes, hypertension, and weight management. They also offer 'Dario Musculoskeletal' for preventing and treating common MSK conditions, and 'Dario' behavioral health solutions to improve access to evidence-based care.
Brands & revenue mix
Primary brand for personalized health management and digital therapeutics.
Separate brand revenue is not available in this research.Source
Digital health platform integrated into DarioHealth's B2B offerings.
Separate brand revenue is not available in this research.Source
Revenue share is not unit sales or a best-seller ranking. Parent brands and included sub-brands can overlap; do not add overlapping rows.
Customer concentrationPREMIUM
As of December 31, 2024, the company reported that a major customer accounted for 41.6% of its accounts receivable.
Wall Street Score
Overall investment score · Quality, value, risk and opportunity
34
Poor
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
30
Poor
Financial Strength
40
Business Quality / Moat
0
Management
75
Growth Quality
9
Risk / Durability
13
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
48
Avoid
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
51/100
Building Historical Record
Model Score 51/100 — estimates relative performance potential, distinct from WallStreetScore (company quality).
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
WSS View
The quick read
WSS currently sees meaningful weaknesses in the company-strength profile.
At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.
The model outlook is currently moderate.
- •Insider activity signal is favorable
- •Elevated debt risk
- •Valuation is a weaker part of the current profile
- •Revenue fundamentals are weak
Company-specific research
Questions worth answering for DRIO
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
- •What is driving DRIO's revenue decline, and does the latest company filing suggest the weakness is temporary or structural?
- •How long can DRIO fund negative free cash flow using its current cash position before it may need more debt or new shares?
- •Is DRIO's debt load manageable relative to cash generation, interest costs and upcoming maturities?
- •What future growth or profitability would be needed to justify DRIO's current valuation?
- •What does the current share basis reconciled warning mean for the reliability or interpretation of DRIO's score?
Essential Investment Snapshot
Wall Street Score
34
Opportunity Score
48
Market Cap
$47.2M
P/E Ratio
9.6
EPS
$0.69
52-Week High
$17.74
52-Week Low
$5.84
Beta
1.12
Intrinsic Value
$5.86
Analyst Target
$14.00
Shares Outstanding
7.3M
Total Revenue
$21.0M
Total Debt
$32.4M
Dividend
No current dividend
Liquidation Value / Share
$7.53
Momentum & Volatility Signals
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
Strong downward momentum
Normal movement
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Notices for DRIO
Detected from reported data — verify before acting.Elevated debt risk
Total debt is at least one year of revenue • Interest coverage is below 2x • Free cash flow is negative
Community Sentiment
0 active · 0 total callsNo personal call yet on DRIO.
What the Bulls Say
- +Product opportunity: DarioHealth Corp. is a digital therapeutics enterprise operating across the United States, Canada, the European Union, Australia, and New Zealand. The company delivers a suite of digital health solutions, including its 'Dario' metabolic programs designed to address conditions like diabetes, hypertension, and weight management. They also offer 'Dario Musculoskeletal' for preventing and treating common MSK conditions, and 'Dario' behavioral health solutions to improve access to evidence-based care.
What the Bears Say
- −Negative free cash flow may increase the need for outside financing and dilution.
Bull and bear cases summarize disclosed catalysts, growth opportunities and risks; they are not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdownWas this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
Score Changes
6 historical score records availablePrevious Score
34
Sep 21, 2026
Change
+0.5
points
Current Score
34
Oct 1, 2026
Category Changes
DRIO increased 0.5 points because Valuation improved by 2.9 points.
Positive Contributors
- + Valuation improved by 2.9 points
Projected Score
Projected Score
38
Projected Change
+3.4%
Preliminary comparable-period financial changes suggest improvement of approximately 3.4 points. This is a projected estimate, not the official WallStreetScore.
Price vs. Value
OvervaluedCurrent Price
$6.46
Intrinsic Value
$5.86
Difference
+$0.60
+10.1% vs IV
Margin of Safety
-10.1%
Related Companies
Medical - SpecialtiesNews
Dario Wins Contract with One of New Jersey's Largest Health Plans Representing 1.5 Million Covered Lives
DarioHealth (NASDAQ:DRIO) Share Price Passes Below Two Hundred Day Moving Average – Here’s What Happened
Pro Medicus (OTCMKTS:PMCUF) versus DarioHealth (NASDAQ:DRIO) Head to Head Survey
Contrasting DarioHealth (NASDAQ:DRIO) and Phreesia (NYSE:PHR)
Related Stock Research
Continue researching this company with related Wall Street Score rankings and investing guides.
Score Alerts
Premium unlocks alerts when a score rises, falls, or reaches your target price.
Start 7-Day Free TrialPortfolio Score
Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.
Start 7-Day Free Trial